Has Crystal Hunter received payments from drug or device companies?

Yes. Drug and device makers reported $611 in general payments to Crystal Hunter across 33 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Crystal Hunter did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Crystal Hunter come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Crystal Hunter

Physician Assistant · Boca Raton, FLNPI 1174384879

Payments from drug & device makers

$611in general payments, 2019–2025

Across 33 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$90
Alkermes, Inc.$73
Neurocrine Biosciences, Inc.$72
AbbVie$66
Takeda Pharmaceuticals U.S.A., Inc.$52
Vanda Pharmaceuticals Inc.$49
plus $209 from 8 others

What the payments were for

Food & beverage$611100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	4	$90
Alkermes, Inc.	4	$73
Neurocrine Biosciences, Inc.	4	$72
AbbVie	4	$66
Takeda Pharmaceuticals U.S.A., Inc.	3	$52
Vanda Pharmaceuticals Inc.	3	$49
Axsome Therapeutics, Inc.	2	$43
Lundbeck LLC	2	$36
Otsuka America Pharmaceutical, Inc.	2	$36
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$20
Teva Pharmaceuticals USA, Inc.	1	$20
Corium, LLC	1	$20
E.r. Squibb & Sons, L.L.C.	1	$19
Almatica Pharma LLC	1	$17

How this compares

$611 in reported general payments places this provider in the 50th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida →

Medicare billing

Part B allowed, 2024

$132,616

Medicare patients

472

Services billed

2,784

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluorouracil	25	$1,814
Fluocinonide	21	$847
Ketoconazole	40	$795
Triamcinolone Acetonide	20	$261
Hydrocortisone	14	$143

Paid to pharmacies, not to this prescriber.

Other physician assistant in Boca Raton

Wendy Yen MendezBoca Raton$116K
Richard MarshallPort Orange$988K
Audrey BeckerSt Augustine$689K
Kevin WilliamsTampa$647K
Brian BonomoLecanto$559K
Melissa SingletonOcala$482K
Reeli ReinuMaitland$427K
Jeanelle KingMiami$424K
Risha BellomoOrlando$397K
Jason BergerClearwater$344K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →